WebNews

Please enter a web search for web results.

NewsWeb

open PR. com
openpr. com > news > 4463847 > future-prospects-key-trends-shaping-the-cellular-therapy

Future Prospects: Key Trends Shaping the Cellular Therapy Tracking Market Until 2030

4+ hour, 4+ min ago  (52+ words) open PR. com We are establishing a secure connection. This website is using a security service to protect itself from online attacks. We are checking your browser to establish a secure connection and keep you safe. Performance & security by bunny....

Gene Online News
geneonline. com > from-delivery-to-control-the-challenge-of-ensuring-cell-and-gene-therapy-designs-survive-reality-at-south-koreas-4th-cgt-congress

From Delivery to Control: The Challenge of Ensuring Cell and Gene Therapy Designs Survive Reality at South Korea's 4th CGT Congress

2+ hour, 31+ min ago  (848+ words) At the 4th Cell & Gene Therapy Innovation & Access Congress Asia, held in Seoul on April 910, 2026, discussions moved beyond questions of scientific feasibility toward a more consequential challenge: whether cell and gene therapies can withstand the realities of manufacturing, delivery, and clinical…...

Seoul Economic Daily
en. sedaily. com > finance > 04/10/2026 > algenomics-partners-with-surgynex-on-lnp-based-rna-gene

Algenomics Partners with Surgynex on LNP-Based RNA Gene Therapy

9+ hour, 31+ min ago  (181+ words) Seoul Economic Daily Algenomics (476830) announced on the 10th that it has signed a strategic memorandum of understanding (MOU) with Surgynex, a company specializing in lipid nanoparticle (LNP) delivery systems, for the development of LNP-based precision-guided next-generation RNA gene therapies. The two…...

@PRNewswire
prnewswire. com > news-releases > accelerating-time-to-data-in-cell-and-gene-therapy-trials-upcoming-webinar-hosted-by-xtalks-302737322. html

Accelerating Time to Data in Cell and Gene Therapy Trials, Upcoming Webinar Hosted by Xtalks

23+ hour, 17+ min ago  (175+ words) Apr 09, 2026, 08: 30 ET In this free webinar, gain insight into the factors impacting speed to data in CGT trials. The featured speakers will share key strategies and processes that can optimize study start-up activities and common operational bottlenecks to accelerate CGT…...

Gene Online News
geneonline. com > cgt-summit-seoul-south-koreas-cell-and-gene-therapy-play-turns-to-manufacturing-access-and-real-world-delivery

CGT Summit Seoul: South Korea's Cell and Gene Therapy Play Turns to Manufacturing, Access, and Real-World Delivery

3+ hour, 27+ min ago  (844+ words) The Asia-Pacific cell and gene therapy (CGT) sector is entering a decisive phase of maturity'one defined less by scientific possibility and more by the ability to translate that science into durable, real-world systems. At the 4th CGT Innovation & Access Congress Asia…...

@onclive
cgtlive. com > view > fda-accepts-ultragenyx-new-bla-submission-mps-iiia-gene-therapy-ux111

FDA Accepts Ultragenyx's New BLA Submission for MPS IIIA Gene Therapy UX111

5+ hour, 9+ min ago  (175+ words) The new PDUFA action date for the BLA has been set at September 19, 2026. The FDA has accepted Ultragenyx's resubmission of a biologics license application (BLA) for UX111 (rebisufligene etisparvovec), an adeno-associated virus serotype 9 vector-based gene therapy intended to treat mucopolysaccharidosis type…...

CPG Click Oil and Gas
en. clickpetroleoegas. com. br > nanogripper-dna-robots-the-size-of-a-cell-bend-fingers-grab-covid-protein-and-lock-the-infection-reprogrammable-they-can-seek-cancer-cells-a-ctl01

Nano Gripper: DNA robots the size of a cell bend fingers, grab COVID protein, and lock the infection; reprogrammable, they can seek cancer cells and deliver medicine to the tumor.

13+ hour, 45+ min ago  (999+ words) Imagine a robot so small it fits inside a cell in your body. In 2026, DNA robots shaped like a "hand" with articulated fingers emerge as a real laboratory technology, built from a single strand of DNA folded like molecular origami....

RAPS. org
raps. org > resource > expert-fda-industry-still-wary-of-enrolling-patients-in-early-cell-and-gene-therapy-trials. html

Expert: FDA, industry still wary of enrolling patients in early cell and gene therapy trials

13+ hour, 51+ min ago  (856+ words) A cutting-edge reference for mastering regulatory intelligence in the age of AI. This 28-chapter guide combines expert insights with real-world stories and practical frameworks. The new member-exclusive RAPS Journal of Regulatory Affairs, a bimonthly, peer-reviewed publication building on the success…...

BIOENGINEER. ORG
bioengineer. org > crispr-screens-reveal-oncogenic-lncrnas-targeted-by-cdk4-6-inhibitors

CRISPR Screens Reveal Oncogenic lnc RNAs Targeted by CDK4/6 Inhibitors

14+ hour, 36+ min ago  (1289+ words) Bioengineer. org In the ever-evolving landscape of cancer research, the discovery of novel therapeutic targets remains a paramount priority. Recently, a groundbreaking study has illuminated a previously uncharted domain within the oncogenic process, focusing on the role of long non-coding…...

Ars Technica
arstechnica. com > science > 2026 > 04 > clinical-trial-shows-gene-editing-works-for-%CE%B2-thalassaemia-too

Clinical trial shows gene editing works for "-Thalassaemia, too

15+ hour, 19+ min ago  (328+ words) Improved gene editing process reactivates the fetal version of a hemoglobin gene. Now, following up on that success, a large Chinese collaboration has followed up with a description of an improved gene editing system that produces more focused changes and…...